Try Alerts Free   |   Login
Health Care › Pharmaceutical Preparations

Catabasis Pharmaceuticals (CATB) Financials and Smart Investor 13F Alerts

See how revenue, income, cash flow, and balance sheet financials have changed over 19 quarters since 2016. Compare with CATB stock chart to see long term trends.

CATB stock compared to

CATB Income Statement

Research & Development Expense:7806000
Total Operating Expenses:10863000
Operating Income:-10863000
Net Income:-10862000
Earnings Per Share, Basic:-0.56
Shares Outstanding, Basic Avg:20084337

CATB Cash Flow

Operating Activities Net Income:
Depreciation, Depletion & Amortization:null
Net Cash from Operations:-9969000
Net Cash from Financing Activities:8940000
Net Cash from Investing Activities:2000000
Net Change in Cash & Equivalents:971000

CATB Balance Sheet

Cash and Cash Equivalents:53091000
Short-Term Investments:null
Total Current Assets:55512000
Total Assets:56850000
Accounts Payable:1408000
Total Short-Term Liabilities:6980000
Total Liabilities:7539000

Major Holders (from 13F filings)

Investment Type
Change
Value (x$1000)
increase or decrease
Blackrock Inc.
1,115,370 sh
7,252 sh
1%
$6,904
-$222
Vanguard Group Inc
812,230 sh
67,442 sh
9%
$5,029
$239
FMR LLC
369,200 sh
369,200 sh
NEW
$2,285
$2,285
Northern Trust Corp
293,422 sh
138,835 sh
90%
$1,817
$823
Oppenheimer & Co Inc
105,721 sh
-1,740 sh
-2%
$654
-$37
Bridgeway Capital Management Inc
90,300 sh
 
$559
Charles Schwab Investment Management Inc
52,845 sh
 
$328
Jacobs Levy Equity Management, Inc
52,167 sh
52,167 sh
NEW
$323
$323
Goldman Sachs Group Inc
30,662 sh
-11,381 sh
-27%
$190
-$80
California State Teachers Retirement System
28,594 sh
1,392 sh
5%
$177
$2
Schonfeld Strategic Advisors LLC
14,000 sh
14,000 sh
NEW
$86
$86
Schonfeld Strategic Advisors LLC
14,000 sh
14,000 sh
NEW
$87
$87
Panagora Asset Management Inc
9,544 sh
277 sh
3%
$59
-$1
Bank Of America Corp /De/
9,265 sh
-15,412 sh
-62%
$57
-$101
Legal & General Group Plc
2,059 sh
-672 sh
-25%
$13
-$5
Morgan Stanley
1,910 sh
-8,306 sh
-81%
$12
-$54
Ameritas Investment Partners, Inc.
1,594 sh
 
$10
Royal Bank Of Canada
91 sh
1 sh
1%
$1
Alyeska Investment Group, L.P.
Call options for 0 sh
-1,125,000 sh
-100%
$0
-$7,234
Renaissance Technologies LLC
0 sh
-104,045 sh
-100%
$0
-$669

Data imported from Catabasis Pharmaceuticals Inc SEC filings. Check original filings before making any investment decision.